420 related articles for article (PubMed ID: 26782036)
1. Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.
Cavagna L; Nuño L; Scirè CA; Govoni M; Longo FJ; Franceschini F; Neri R; Castañeda S; Sifuentes Giraldo WA; Caporali R; Iannone F; Fusaro E; Paolazzi G; Pellerito R; Schwarting A; Saketkoo LA; Ortego-Centeno N; Quartuccio L; Bartoloni E; Specker C; Pina Murcia T; La Corte R; Furini F; Foschi V; Bachiller Corral J; Airò P; Cavazzana I; Martínez-Barrio J; Hinojosa M; Giannini M; Barsotti S; Menke J; Triantafyllias K; Vitetta R; Russo A; Bogliolo L; Bajocchi G; Bravi E; Barausse G; Bortolotti R; Selmi C; Parisi S; Salaffi F; Montecucco C; González-Gay MA;
Clin Rev Allergy Immunol; 2017 Feb; 52(1):71-80. PubMed ID: 26782036
[TBL] [Abstract][Full Text] [Related]
2. Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.
Cavagna L; Nuño L; Scirè CA; Govoni M; Longo FJL; Franceschini F; Neri R; Castañeda S; Giraldo WAS; Caporali R; Iannone F; Fusaro E; Paolazzi G; Pellerito R; Schwarting A; Saketkoo LA; Ortego-Centeno N; Quartuccio L; Bartoloni E; Specker C; Murcia TP; La Corte R; Furini F; Foschi V; Corral JB; Airò P; Cavazzana I; Martínez-Barrio J; Hinojosa M; Giannini M; Barsotti S; Menke J; Triantafyllias K; Vitetta R; Russo A; Bajocchi G; Bravi E; Barausse G; Bortolotti R; Selmi C; Parisi S; Montecucco C; González-Gay MA;
Medicine (Baltimore); 2015 Aug; 94(32):e1144. PubMed ID: 26266346
[TBL] [Abstract][Full Text] [Related]
3. Clinical spectrum of anti-Jo-1-associated disease.
Monti S; Montecucco C; Cavagna L
Curr Opin Rheumatol; 2017 Nov; 29(6):612-617. PubMed ID: 28796005
[TBL] [Abstract][Full Text] [Related]
4. Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.
González-Gay MA; Montecucco C; Selva-O'Callaghan A; Trallero-Araguas E; Molberg O; Andersson H; Rojas-Serrano J; Perez-Roman DI; Bauhammer J; Fiehn C; Neri R; Barsotti S; Lorenz HM; Doria A; Ghirardello A; Iannone F; Giannini M; Franceschini F; Cavazzana I; Triantafyllias K; Benucci M; Infantino M; Manfredi M; Conti F; Schwarting A; Sebastiani G; Iuliano A; Emmi G; Silvestri E; Govoni M; Scirè CA; Furini F; Lopez-Longo FJ; Martínez-Barrio J; Sebastiani M; Manfredi A; Bachiller-Corral J; Sifuentes Giraldo WA; Cimmino MA; Cosso C; Belotti Masserini A; Cagnotto G; Codullo V; Romano M; Paolazzi G; Pellerito R; Saketkoo LA; Ortego-Centeno N; Quartuccio L; Batticciotto A; Bartoloni Bocci E; Gerli R; Specker C; Bravi E; Selmi C; Parisi S; Salaffi F; Meloni F; Marchioni E; Pesci A; Dei G; Confalonieri M; Tomietto P; Nuno L; Bonella F; Pipitone N; Mera-Valera A; Perez-Gomez N; Gerzeli S; Lopez-Mejias R; Matos-Costa CJ; Pereira da Silva JA; Cifrian J; Alpini C; Olivieri I; Blázquez Cañamero MÁ; Rodriguez Cambrón AB; Castañeda S; Cavagna L;
Clin Exp Rheumatol; 2018; 36(1):44-49. PubMed ID: 28770709
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q
BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248
[TBL] [Abstract][Full Text] [Related]
6. Myositis-related interstitial lung disease and antisynthetase syndrome.
Solomon J; Swigris JJ; Brown KK
J Bras Pneumol; 2011; 37(1):100-9. PubMed ID: 21390438
[TBL] [Abstract][Full Text] [Related]
7. Interstitial lung disease in a patient with antisynthetase syndrome and no myositis.
Plastiras SC; Soliotis FC; Vlachoyiannopoulos P; Tzelepis GE
Clin Rheumatol; 2007 Jan; 26(1):108-11. PubMed ID: 16328094
[TBL] [Abstract][Full Text] [Related]
8. [The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].
Szabó K; Nagy-Vincze M; Bodoki L; Hodosi K; Dankó K; Griger Z
Orv Hetil; 2016 Apr; 157(15):575-83. PubMed ID: 27039996
[TBL] [Abstract][Full Text] [Related]
9. Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome.
Cavagna L; Fusetti C; Montecucco C; Caporali R
J Rheumatol; 2010 Sep; 37(9):1967; author reply 1968. PubMed ID: 20810525
[No Abstract] [Full Text] [Related]
10. Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.
Bartoloni E; Gonzalez-Gay MA; Scirè C; Castaneda S; Gerli R; Lopez-Longo FJ; Martinez-Barrio J; Govoni M; Furini F; Pina T; Iannone F; Giannini M; Nuño L; Quartuccio L; Ortego-Centeno N; Alunno A; Specker C; Montecucco C; Triantafyllias K; Balduzzi S; Sifuentes-Giraldo WA; Paolazzi G; Bravi E; Schwarting A; Pellerito R; Russo A; Selmi C; Saketkoo LA; Fusaro E; Parisi S; Pipitone N; Franceschini F; Cavazzana I; Neri R; Barsotti S; Codullo V; Cavagna L
Autoimmun Rev; 2017 Mar; 16(3):253-257. PubMed ID: 28147261
[TBL] [Abstract][Full Text] [Related]
11. Anti-Jo-1 myositis and the antiphospholipid syndrome showing right ventricular thrombus: a novel overlap syndrome with atypical presentation.
Wang CH; Wang NC; Lin TY; Chen CH
Mod Rheumatol; 2014 Sep; 24(5):865-8. PubMed ID: 24517557
[TBL] [Abstract][Full Text] [Related]
12. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
Stanciu R; Guiguet M; Musset L; Touitou D; Beigelman C; Rigolet A; Costedoat-Chalumeau N; Allenbach Y; Hervier B; Dubourg O; Maisonobe T; Charuel JL; Behin A; Herson S; Amoura Z; Grenier P; Benveniste O
J Rheumatol; 2012 Sep; 39(9):1835-9. PubMed ID: 22859355
[TBL] [Abstract][Full Text] [Related]
13. Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course.
Cavagna L; Trallero-Araguás E; Meloni F; Cavazzana I; Rojas-Serrano J; Feist E; Zanframundo G; Morandi V; Meyer A; Pereira da Silva JA; Matos Costa CJ; Molberg O; Andersson H; Codullo V; Mosca M; Barsotti S; Neri R; Scirè C; Govoni M; Furini F; Lopez-Longo FJ; Martinez-Barrio J; Schneider U; Lorenz HM; Doria A; Ghirardello A; Ortego-Centeno N; Confalonieri M; Tomietto P; Pipitone N; Rodriguez Cambron AB; Blázquez Cañamero MÁ; Voll RE; Wendel S; Scarpato S; Maurier F; Limonta M; Colombelli P; Giannini M; Geny B; Arrigoni E; Bravi E; Migliorini P; Mathieu A; Piga M; Drott U; Delbrueck C; Bauhammer J; Cagnotto G; Vancheri C; Sambataro G; De Langhe E; Sainaghi PP; Monti C; Gigli Berzolari F; Romano M; Bonella F; Specker C; Schwarting A; Villa Blanco I; Selmi C; Ceribelli A; Nuno L; Mera-Varela A; Perez Gomez N; Fusaro E; Parisi S; Sinigaglia L; Del Papa N; Benucci M; Cimmino MA; Riccieri V; Conti F; Sebastiani GD; Iuliano A; Emmi G; Cammelli D; Sebastiani M; Manfredi A; Bachiller-Corral J; Sifuentes Giraldo WA; Paolazzi G; Saketkoo LA; Giorgi R; Salaffi F; Cifrian J; Caporali R; Locatelli F; Marchioni E; Pesci A; Dei G; Pozzi MR; Claudia L; Distler J; Knitza J; Schett G; Iannone F; Fornaro M; Franceschini F; Quartuccio L; Gerli R; Bartoloni E; Bellando Randone S; Zampogna G; Gonzalez Perez MI; Mejia M; Vicente E; Triantafyllias K; Lopez-Mejias R; Matucci-Cerinic M; Selva-O'Callaghan A; Castañeda S; Montecucco C; Gonzalez-Gay MA
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31752231
[TBL] [Abstract][Full Text] [Related]
14. [Antisynthetase syndromes].
Bauhammer J; Fiehn C
Z Rheumatol; 2019 Sep; 78(7):645-655. PubMed ID: 31346706
[TBL] [Abstract][Full Text] [Related]
15. [The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].
Häussermann A; Gillissen A; Seidel W
Pneumologie; 2010 Aug; 64(8):496-503. PubMed ID: 20387195
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic plasma exchange in antisynthetase syndrome with severe interstitial lung disease.
Omotoso BA; Ogden MI; Balogun RA
J Clin Apher; 2015 Dec; 30(6):375-9. PubMed ID: 25727180
[TBL] [Abstract][Full Text] [Related]
17. Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide.
Lange U; Piegsa M; Müller-Ladner U; Strunk J
Autoimmunity; 2006 May; 39(3):261-4. PubMed ID: 16769661
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory Histidyl-Transfer RNA Synthetase-Specific CD4+ T Cells in the Blood and Lungs of Patients With Idiopathic Inflammatory Myopathies.
Galindo-Feria AS; Albrecht I; Fernandes-Cerqueira C; Notarnicola A; James EA; Herrath J; Dastmalchi M; Sandalova T; Rönnblom L; Jakobsson PJ; Fathi M; Achour A; Grunewald J; Malmström V; Lundberg IE
Arthritis Rheumatol; 2020 Jan; 72(1):179-191. PubMed ID: 31403245
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of autoantibody screening in patients with autoimmune myositis.
Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
[TBL] [Abstract][Full Text] [Related]
20. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
Preger C; Notarnicola A; Hellström C; Wigren E; Fernandes-Cerqueira C; Kvarnström M; Wahren-Herlenius M; Idborg H; Lundberg IE; Persson H; Gräslund S; Jakobsson PJ
J Autoimmun; 2023 Jan; 134():102951. PubMed ID: 36470210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
